Edwards Lifesciences Corporation Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax
Edwards Lifesciences Corporation (EW) reported Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax of -$14.40 million for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Income Statement › Other Income
us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax · last filed 2013-11-07
- Edwards Lifesciences Corporation unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2013-09-30 was -$14.40M.
- Edwards Lifesciences Corporation unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2012-09-30 was -$9.50M.
| Period end | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 3 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 9 month |
|---|---|---|
| 2013-09-30 | -$14.40M 10-Q · filed 2013-11-07 | $13.30M 10-Q · filed 2013-11-07 |
| 2012-09-30 | -$9.50M 10-Q · filed 2013-11-07 | $3.90M 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |